drugset / Trial / NCT02152514

RCT Comparing Analgesia Post-VATS With Epimorph VS Placebo

NCT02152514

Phase 4 Terminated 34 enrolled University of Sherbrooke
RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of the study is to determine if the administration of a mix of Sufentanil and Morphine in intrathecal is a better analgesia regimen than PCA alone in patient post-VATS.

Timeline

Start
2013-04
Primary completion
2015-05
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Morphine Other / unclassified 250 ug Intrathecal
Comparator Sufentanil Other / unclassified 10 ug Intrathecal

Indications

No indication recorded.